Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
BMC Cancer|May 1, 2015
Everolimus in metastatic renal cell carcinoma after failure of initial anti-VEGF therapy: final results of a noninterventional studyLothar Bergmann, Ulrich Kube, Christian Doehn, et al.
International Journal of Cancer|February 9, 2023
First-line nab-paclitaxel plus carboplatin for patients with advanced non-small cell lung cancer: Final results of the NEPTUN studyTobias Dechow, Jorge Riera-Knorrenschild, Björn Hackanson, et al.
Onkologie|March 15, 2013
Everolimus in metastatic renal cell carcinoma after failure of initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFr-TKI) therapy: results of an interim analysis of a non-interventional studyLothar Bergmann, Peter J Goebell, Ulrich Kube, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 4, 2011
Efficacy of an artificial neural network-based approach to endoscopic ultrasound elastography in diagnosis of focal pancreatic massesAdrian Săftoiu, Peter Vilmann, Florin Gorunescu, et al.
RSC Advances|May 11, 2022
Design of triphasic poly(lactic-co-glycolic acid) nanoparticles containing a perfluorocarbon phase for biomedical applicationsEdyta Swider, Alexander H J Staal, N Koen van Riessen, et al.
International Immunopharmacology|January 11, 2017
Rapid infusions of human normal immunoglobulin 50g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopeniaGiuseppe Spadaro, Alessandra Vultaggio, A Alberto Bosi, et al.
Leukemia & Lymphoma|December 10, 2024
Treatment adherence and effectiveness in patients treated with carfilzomib-based therapy combinations for relapsed/refractory multiple myeloma in Germany: interim results from the non-interventional CARO studyWolfgang Knauf, Jens Uhlig, Eyck von der Heyde, et al.
International Journal of Cancer|March 6, 2026
Real-world progression-free survival and overall survival in patients with HR+/HER2- advanced breast cancer treated in first-line with ribociclib, endocrine monotherapy or chemotherapy: Results from the observational RIBANNA studyPeter A Fasching, Cosima Brucker, Thomas Decker, et al.
Atherosclerosis|September 3, 2002
Evidence of insulin resistant lipid metabolism in adipose tissue in familial combined hyperlipidemia, but not type 2 diabetes mellitusCarla J H van der Kallen, Christine Voors-Pette, Freek G Bouwman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2019
Phase II Study of the ALK5 Inhibitor Galunisertib in Very Low-, Low-, and Intermediate-Risk Myelodysplastic SyndromesValeria Santini, David Valcárcel, Uwe Platzbecker, et al.
Pageof 4